Amarin’s U.S. Patent Protection For Vascepa Seeking Alpha
Amarin has patent protection for Vascepa® out to 2030, including protection related to the possible expanded Reduce-It trial label. Two U.S. formulation patents.
Amarin’s U.S. Patent Protection For Vascepa Seeking Alpha
Amarin has patent protection for Vascepa® out to 2030, including protection related to the possible expanded Reduce-It trial label. Two U.S. formulation patents.